Skip to search formSkip to main contentSkip to account menu

Vimpat

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
This article presents the review of the most significant studies of the efficacy and tolerability of lacosamide (LCM) in… 
Review
2016
Review
2016
Many patients with epilepsy receive treatment in polytherapy. Selection of antiepileptic drugs (AEDs) for the combination should… 
2016
2016
OBJECTIVE To evaluate the efficacy and tolerability of intravenous lacosamide (vimpat) in inpatients with frequent partial-onset… 
Review
2012
Review
2012
The new antiepileptic drug (AED) lacosamide (vimpat, "UCB Pharma") with a new mechanism of action was registered in Russia in… 
2011
2011
The novel antiepileptic drug, (R)-N-benzyl 2-acetamido-3-methoxypropionamide ((R)-lacosamide, Vimpat(®) ((R)-1)), was recently… 
2009
2009